Fig. 5
Receiver operating characteristic curves for mid-treatment ADC200,1000 change (ΔADC200,1000) and regression model (ΔADC200,1000 + estrogen receptor [ER] + human epidermal growth factor receptor 2 [HER2]) as predictors of pathologic complete response. The areas under the receiver operating characteristic curves were 0.831 (95% confidence interval: 0.747, 0.915) and 0.905 (95% confidence interval: 0.843, 0.966), respectively